Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Great opportunities but yet no promotions or accolades.
Was ist das Beste an Ihrem Vergütungspaket?
the compensation and the benefits and holidays.
Was muss geändert werden, um die Unternehmenskultur zu verbessern?
Respect, value across all departments, leads african american-
Was sind einige der besten Dinge an Ihrem Team?
experience and knowledge and accountabilty
Was braucht das Führungsteam, um besser zu werden?
Valuing employees who have been with the company over 2 years
Was macht Sie bei der Arbeit am glücklichsten?
Executing on my responsibilities in such way to advance the company's goals.
Other Employee Reviews for Karyopharm Therapeutics
×